We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Fluidic Nanodevices Created by Liquid 3D Printing

By LabMedica International staff writers
Posted on 08 May 2019
Researchers have used a novel three-dimensional (3D) printing technique to create an all-liquid fluidic device that is capable performing a wide range of applications - from making battery materials to screening drug candidates.

Systems comprised of immiscible liquids held in non-equilibrium shapes by the interfacial assembly and jamming of nanoparticle-polymer surfactants have significant potential to advance catalysis, chemical separations, energy storage, and conversion. More...
However, directing spatial functionality within them and coupling processes in both phases has remained a challenge.

Investigators at Lawrence Berkeley National Laboratory (CA, USA) exploited nanoclay-polymer surfactant assemblies at an oil-water interface to produce a semi-permeable membrane between the liquids. Flow channels were fabricated using micropatterned two-dimensional (2D) substrates and liquid-in-liquid three-dimensional printing. The anionic walls of the device were functionalized with cationic small molecules, enzymes, and colloidal nanocrystal catalysts. Three-dimensional printing was used to build bridges between channels, connecting them so that a chemical flowing through them encountered catalysts in a specific order, setting off a cascade of chemical reactions to make specific chemical compounds.

The investigators reported in the March 6, 2019, online edition of the journal Nature Communications that multi-step chemical transformations could be conducted within the channels under flow, as could selective mass transport across the liquid-liquid interface for in-line separations. Ultimately, these all-liquid systems were automated using pumps, detectors, and control systems, revealing a latent ability for chemical logic and learning.

"What we demonstrated is remarkable. Our three-dimensional printed device can be programmed to carry out multistep, complex chemical reactions on demand," said senior author Dr. Brett Helms, staff scientist at Lawrence Berkeley National Laboratory. "What is even more amazing is that this versatile platform can be reconfigured to efficiently and precisely combine molecules to form very specific products, such as organic battery materials. The form and functions of these devices are only limited by the imagination of the researcher. Autonomous synthesis is an emerging area of interest in the chemistry and materials communities, and our technique for three-dimensional printing devices for all-liquid flow chemistry could help to play an important role in establishing the field."

Related Links:
Lawrence Berkeley National Laboratory


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gastrointestinal Panel
Xpert® GI Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.